Aradigm (ARDM) Stock Research, Analysis & News

Quick Analysis on Aradigm (ARDM) Stock as of August 22, 2017

Previous Closing Price $1.27 is below its 50 day moving average $1.33
Previous Closing Price $1.27 is below its 200 day moving average $1.48
The Stock pays no dividend
The closing price $1.27 is more than 490.55% away from its one year target price of $7.5000
Good Price to Sale Ratio 1.9204
Current Short Ratio 1.3900 is great than 1
Earning per Share $-1.2690 is negative. Aradigm is lossing money.
EBITDA $-14.99M is negative
Average trading volume is relatively low at 37,608
It is a very small cap stock with market cap of $18.46M
(See more information about Aradigm (ARDM) Stock below)

Aradigm (ARDM) Stock Profile Summary

Aradigm Corporation, a pharmaceutical company, engages in the development and commercialization of drugs delivered by inhalation for the treatment of respiratory diseases by pulmonologists in the United States. The companys activities include development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary arterial hypertension, chronic obstructive pulmonary disease, inhalation anthrax infections, and smoking cessation. Its products include ARD-3100, a Phase II clinical trials product for the treatment of cystic fibrosis; ARD-3150, a Phase II clinical trials product targeting bronchiectasis; ARD-1600, a Phase I clinical trials product for the treatment of tobacco smoking cessation; and ARD-1100, a preclinical trials product for the treatment of inhalation anthrax indications. Aradigm Corporation has a license, development, and commercialization agreement with Lung Rx to develop and commercialize inhaled treprostinil using the companys AERx Essence technology for the treatment of pulmonary arterial hypertension and other potential therapeutic indications. The company was founded in 1991 and is headquartered in Hayward, California.

Aradigm (ARDM) Stock Key Statistics Research and Analysis as of August 22, 2017

Stock ExchangeNCM
Market Capitalization$18.46M
Trade Volume (Average Trading Volume)1,337 (37,608)
Price/Sales1.9204
Earning/Share$-1.2690
Current Year EPS Estimate$-0.7400
Next Year EPS Estimate$-0.4000
Previous Closing Price$1.27
50 Day Price Moving Average$1.33
200 Day Price Moving Average$1.48
Dividend Yield0.0000%
1 yr Target Price$7.5000
PEG Ratio0.0000
Short Ratio1.3900
EBITDA$-14.99M

Latest Market News on Aradigm (ARDM)


Click here to find the latest news on Aradigm (ARDM)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center